Ipsogen.
Ipsogen is a molecular diagnostics company focused on the development and commercialization of innovative tests used to guide and personalize treatment options in cancer. Ipsogen has built a comprehensive portfolio of unique blood cancer diagnostic products available worldwide to leading cancer care institutions in more than 50 countries. Ipsogen's core expertise is focused on large-scale gene expression profiling of tumors in a clinical context, and includes proven know-how for the translation of discoveries into industry standard diagnostic tools. This is achieved, for blood cancers, by an array of individual DNA or RNA tests targeting known anomalies, and for breast cancer by expression profiling and interpretation of the results on the basis of extensive retrospective and prospective studies performed by the company. These products and services make personalized cancer treatment both possible and effective.